---
title: "Emerge vs OrderlyMeds: GLP-1 costs and terms compared"
description: "How Emerge and OrderlyMeds compare on GLP-1 costs, billing interval, commitment and cancellation, ordered alphabetically, with the buyer guide rank and score each one already carries."
---

# Emerge vs OrderlyMeds

Canonical page: https://glp1buyerguide.com/head-to-head/emerge-vs-orderlymeds


Emerge vs OrderlyMeds: which offers better value on GLP-1 injections?

## Short answer

Neither program wins this pairing outright: the lower tirzepatide charge sits with Emerge, OrderlyMeds is the only one of the two that sells semaglutide, and the two charge on different cycles. Tirzepatide: $75 a month lower at Emerge, about 25% less than $299. Semaglutide: Emerge does not sell semaglutide at all, so OrderlyMeds's recorded $149 stands alone on this molecule and there is no second charge to compare it with. Neither records a separate membership fee, so the recorded charge is the whole recurring price on both sides. The two charges do not cover the same length of time: Emerge bills every 28 days, while OrderlyMeds bills once a calendar month. A four-week cycle repeats more often in a year than a calendar month does, so the recorded gap between the two charges is not a like-for-like monthly saving, and no annual total is printed here because neither program bills one.

## Same fields, side by side

Two recorded programs compared on the same fields. The first two rows carry the rank and score each program already holds in the buyer guide index, so the standing sits beside the figures rather than apart from them. A field that is unestablished is printed as unestablished, not as an empty cell and not as a zero.

| Field | Emerge | OrderlyMeds |
| --- | --- | --- |
| Buyer guide rank | Rank 11 | Rank 9 |
| Buyer guide score | 82.1 / 100 | 84.0 / 100 |
| Tirzepatide, standard month | $224 a month, checked October 22, 2026 | $299 a month, checked October 15, 2026 |
| Semaglutide, standard month | Not offered, checked October 26, 2026 | $149 a month, checked October 26, 2026 |
| Membership fee | $0: no separate membership fee | $0: no separate membership fee |
| Included services | Medication, prescribing, syringes, overnight shipping and medical oversight. | Tirzepatide: Doctor-led orientation, medication if prescribed, supplies and shipping. · Semaglutide: Provider review, medication if prescribed, supplies and shipping. |
| Required or separate fees | No signup fee, no doctor or consultation fee and no shipping fee. The plan price is the whole price. | Tirzepatide: No separate membership fee; virtual consults included. · Semaglutide: No separate membership fee recorded. |
| Dose increases | The recorded charge steps up with the dose: $224 at 2.5 mg, $239 at 5 mg, $249 at 7.5 mg, $269 at 10 mg, $279 at 12.5 mg and $289 at 15 mg, each on its own recorded billing interval. 12.5 mg and 15 mg are listed for existing patients only. No charge is assumed above the highest dose listed. | One price across the doses listed; no advertised dose-based increase. The published dose range is not established. |
| Billing interval | Every 28 days. | Monthly, calendar-month billing. |
| Commitment | Auto-renews on the recorded billing cadence until canceled. Each charge covers 4 weeks as published. The minimum term is not established from the reviewed terms; the cancellation conditions are recorded on this offer. | Tirzepatide: No minimum term on the monthly plan. · Semaglutide: No long-term commitment. Recurring billing applies until you cancel. |
| Cancellation | Request cancellation by the support text or email already used for the account. No multi-period minimum. | Cancel before the next renewal to stop future charges. |
| Refund conditions | A $10 processing fee applies after intake processing but before an order is placed. The reviewed FAQ does not establish a general post-order refund entitlement. | Not established. |
| Dispensing pharmacy | Not established. No dispensing facility is recorded for this program on the pages we read, so no pharmacy is attributed here. | Not established. No dispensing facility is recorded for this program on the pages we read, so no pharmacy is attributed here. |

## Bottom line

On value the two split: one is cheaper on the molecule both of them sell, the other is the only one that sells the second molecule at all. Tirzepatide: $75 a month lower at Emerge, about 25% less than $299. Semaglutide: Emerge does not sell semaglutide at all, so OrderlyMeds's recorded $149 stands alone on this molecule and there is no second charge to compare it with. On the terms they split in a different place. One side publishes a charge against each dose it lists, so the cost of a dose increase is visible before treatment starts, but it offers no semaglutide and states it does not serve California. The other records a flat charge on both molecules and a cancellation line that stops future charges before the next renewal, but does not publish the dose range its flat charge covers. The refund field separates them too: Emerge answers it with a recorded condition, while OrderlyMeds leaves it unestablished. A recorded condition is not the same thing as a generous one, and an unestablished field is neither a refund right nor a refusal of one. Neither record establishes which facility dispenses the compounded product, so that field stays unestablished on both sides. Where either record leaves a field unanswered it is printed as unestablished here. A blank is not a zero, it is not a reason to prefer the other side, and no charge has been converted between billing cycles to make the two look comparable.

## Where each side wins and where it does not

Every line below points at a field printed in the table above, so it can be checked against the record rather than taken on trust. A disadvantage is a documented weakness in the recorded terms, not a defect in the medication, and nothing here is a recommendation.

### Emerge

**Advantages**

- Holds the lower recorded tirzepatide charge at the doses it prices: $224 at its lowest dose against $299 at OrderlyMeds, each on its own recorded billing period.
- Publishes a charge against each dose it lists, so what a dose increase costs is stated before treatment starts rather than discovered on a later bill.
- Records no separate membership fee, so the recorded dose charge is the whole recurring price.
- Records the medication, prescribing and shipping inside the single charge rather than as separate line items.
- Answers the refund field with a recorded condition, where the other program leaves that field unestablished.

**Disadvantages**

- Does not sell semaglutide at all, so it is not an option on that molecule.
- Bills every 28 days, so a year takes more than twelve charges and the gap with a calendar-month charge is not a like-for-like monthly saving.
- Records a processing fee on a cancellation made after intake has been processed but before an order is placed, and does not establish a general post-order refund entitlement.
- Cancellation runs through the support thread already used for the account rather than a self-service switch described on the page.
- Records no dispensing facility, so which pharmacy fills an order stays unestablished.
- States it does not serve California, on its own recorded availability note.

### OrderlyMeds

**Advantages**

- Is the only one of the two that sells semaglutide, recorded at $149 on this page.
- Bills once a calendar month, so twelve charges cover a year.
- Records no multi-period minimum, with cancellation stated as stopping future charges before the next renewal.
- Records one flat charge across the doses it lists, so the recorded price does not step up with the dose.
- Records no separate membership fee, so the recorded charge is the whole recurring price.

**Disadvantages**

- Holds the higher recorded tirzepatide charge of the two: $299 against $224 at Emerge.
- Records no refund condition at all, so what happens to a payment already taken stays unestablished rather than settled.
- Does not publish the dose range its flat charge covers, so the flat price cannot be checked above the doses it lists.
- Records no dispensing facility, so which pharmacy fills an order stays unestablished.

A list of advantages is not a ranking. The buyer guide position each program holds, if any, is printed in the table above from that index, and it was not altered for this page.

**Price and billing terms only.** Compounded and brand-name products appear together because buyers compare them. They can share an active ingredient; they are not the same product. Compounded medications are not FDA-approved and are not generic versions of the brand-name medications.

## Sources and check dates

Each row above is read from the provider page listed for that program, and each figure keeps the date that page was read rather than a single freshness badge for the comparison. A field a source did not answer is printed as unestablished instead of being inferred from the other side.

### Emerge

- https://www.emergeweight.com/pricing — dose-based pricing $224 to $289 a month, checked October 15, 2026
- https://www.emergeweight.com/hsa-fsa — terms, cancellation and refunds, checked October 22, 2026
- https://www.emergeweight.com/faq — terms, cancellation and refunds, checked October 22, 2026

### OrderlyMeds

- https://orderlymeds.com/pricing/ — published price and billing terms, checked October 26, 2026

Prices and terms move. A figure here is accurate to its own check date and no further, and a plan can change or be withdrawn after that date.

## Related recorded pages

- [All head-to-head comparisons](https://glp1buyerguide.com/head-to-head)
- [Full comparison ledger](https://glp1buyerguide.com/compare)
- [How we compare](https://glp1buyerguide.com/how-we-compare)
- [Disclosures](https://glp1buyerguide.com/disclosures)